Esther C. H. Uijttewaal

Esther C. H. Uijttewaal

Auto-generated profile, based on publicly available information

Esther C. H. Uijttewaal

Institute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC) 3 , Vienna

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2024 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
EUEsther C. H. Uijttewaal
Esther C. H. Uijttewaal
JLJoonsun Lee
Joonsun Lee
ASAnnika Charlotte Sell
Annika Charlotte Sell
NBNaomi Botay
Naomi Botay
GVGintautas Vainorius
Gintautas Vainorius
UEUlrich Elling
Ulrich Elling
Pooled genetic screening with CRISPR–Cas9 has enabled genome-wide, high-resolution mapping of genes to phenotypes, but assessing the effect of a given genetic perturbation requires evaluation of each single guide RNA (sgRNA) in hundreds of cells to counter stochastic genetic drift and obtain robust results. However, resolution is limited in complex, heterogeneous models, such as organoids or tumors transplanted into mice, because achieving sufficient representation requires impractical scaling. This is due to bottleneck effects and biological heterogeneity of cell populations. Here we introduce CRISPR-StAR, a screening method that uses internal controls generated by activating sgRNAs in only half the progeny of each cell subsequent to re-expansion of the cell clone. Our method overcomes both intrinsic and extrinsic heterogeneity as well as genetic drift in bottlenecks by generating clonal, single-cell-derived intrinsic controls. We use CRISPR-StAR to identify in-vivo-specific genetic dependencies in a genome-wide screen in mouse melanoma. Benchmarking against conventional screening demonstrates the improved data quality provided by this technology.

2 July 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
RLRui Lopes
Rui Lopes
KSKathleen Sprouffske
Kathleen Sprouffske
CSCaibin Sheng
Caibin Sheng
EUEsther C. H. Uijttewaal
Esther C. H. Uijttewaal
AWAdriana Emma Wesdorp
Adriana Emma Wesdorp
GGGiorgio G. Galli
Giorgio G. Galli
Combination of functional epigenomics and single-cell CRISPR screens reveals that ER exerts its oncogenic role via downstream TFs.

8 June 2026 in Journal of Cell Biology
Verified
Journal Article
Open access
MNMarjana Ndoci
Marjana Ndoci
SBSharanya Bhattacharya
Sharanya Bhattacharya
IAIshita Agrawal
Ishita Agrawal
YHYvonne Hinze
Yvonne Hinze
KLKathrin Lemke
Kathrin Lemke
SDSoni Deshwal
Soni Deshwal
Coenzyme Q (CoQ) is a hydrophobic lipid primarily synthesized in the mitochondria, though it is also present in non-mitochondrial membranes. However, the metabolic pathways that regulate intracellular CoQ distribution are unknown. This study identifies a key role for the mevalonate pathway in regulating CoQ distribution. The mevalonate pathway synthesizes isopentenyl pyrophosphate (IPP) as the precursor metabolite for both CoQ and cholesterol. We show that CoQ synthesis remains stable regardless of whether the mevalonate pathway is upregulated or downregulated. Upregulation of HMG-CoA reductase (HMGCR), indicative of increased mevalonate flux, enhances cholesterol ester synthesis without altering CoQ levels. When the pathway is downregulated, cholesterol synthesis declines, yet mitochondrial CoQ levels are preserved. Under these limiting conditions, mitochondria reduce CoQ export to maintain their internal CoQ pool. While this adaptation sustains mitochondrial respiration, it diminishes extramitochondrial CoQ availability and sensitizes cells to ferroptosis. These findings uncover a mitochondria-driven mechanism that preserves respiratory function by prioritizing CoQ retention during metabolic stress.